<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01714063</url>
  </required_header>
  <id_info>
    <org_study_id>RDD-2010-001</org_study_id>
    <nct_id>NCT01714063</nct_id>
  </id_info>
  <brief_title>Drug Delivery Via Pressurized Metered-dose Inhaler and Valved Holding Chamber in Asthmatic Children: Determination of Delivered Dose Following Coordinated and Uncoordinated Use</brief_title>
  <official_title>Drug Delivery Via Pressurized Metered-dose Inhaler and Valved Holding Chamber in Asthmatic Children: Determination of Delivered Dose Following Coordinated and Uncoordinated Use</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Philips Respironics</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Philips Respironics</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The primary objective of this study is to determine ex vivo the amount of fluticasone
      deposited onto a filter (delivered dose) interposed between the OptiChamber Diamond Valved
      Holding Chamber (VHC) mouthpiece and the subject's mouth during coordinated and uncoordinated
      actuation/inhalation maneuver.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>December 2012</start_date>
  <completion_date type="Actual">July 2014</completion_date>
  <primary_completion_date type="Actual">July 2014</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Delivered Dose of Fluticasone (on the Filter)</measure>
    <time_frame>Day 1</time_frame>
    <description>This is a measure of the the amount of fluticasone deposited onto a filter (delivered dose) during coordinated and uncoordinated actuation/inhalation maneuver. The coordinated maneuver occurs when the firing of the fluticasone is coordinated with the inhalation of the patient . An uncoordinated maneuver occurs when the firing of the fluticasone is coordinated with the exhalation of the patient.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Delivered Dose of Fluticasone (on the Filter) Comparing Coordinated and Uncoordinated Maneuvers</measure>
    <time_frame>Day 1</time_frame>
    <description>This is a measure of the the amount of fluticasone deposited onto a filter (delivered dose) during coordinated and uncoordinated actuation/inhalation maneuver. The coordinated maneuver occurs when the firing of the fluticasone is coordinated with the inhalation of the patient . An uncoordinated maneuver occurs when the firing of the fluticasone is coordinated with the exhalation of the patient.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Inspiratory Peak Flow</measure>
    <time_frame>Day 1</time_frame>
    <description>Inspiratory peak flow is a person's maximum speed of inspiration, as measured with a peak flow meter, a small, hand-held device used to monitor a person's ability to breathe in air.
This study compared the inspiratory peak flows of all participants between the coordinated and uncoordinated maneuvers.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Inspiratory Tidal Volume</measure>
    <time_frame>Day 1</time_frame>
    <description>Inspiratory tidal volume is a person's lung volume representing the normal volume of air displaced between normal inhalation and exhalation when extra effort is not applied. In a healthy, young human adult, tidal volume is approximately 500 mL per inspiration or 7 mL/kg of body mass.
This study compared the inspiratory tidal volume of all participants between the coordinated and uncoordinated maneuvers.</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Measurement Residual Amount of Drug (Fluticasone) Deposited Within the OptiChamber Diamond VHC</measure>
    <time_frame>Day 1</time_frame>
    <description>Collect the residual amount of drug (fluticasone) deposited within the OptiChamber Diamond VHC by washing the internal surfaces of the VHC and the Pressurized Metered Dose Inhaler (pMDI) boot</description>
  </other_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">34</enrollment>
  <condition>Asthma</condition>
  <arm_group>
    <arm_group_label>Age 5-6.5</arm_group_label>
    <description>Group 1 will consist of 16 children aged 5-6.5 years</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Aged 6.6- 8 years</arm_group_label>
    <description>Group 2 will consist of 16 children aged 6.6- 8 years</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Pressurized Metered-Dose Inhaler</intervention_name>
    <description>Pressurized Metered-Dose Inhaler</description>
    <arm_group_label>Age 5-6.5</arm_group_label>
    <arm_group_label>Aged 6.6- 8 years</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        40 subjects aged 5-8 diagnosed with asthma
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  â€¢ Asthmatic children between the ages of 5 and 8 followed at Arkansas Children's
             Hospital.

               -  The subjects must be available to complete the study.

               -  The subject's parent(s) and/or the subject's legal guardian must provide written
                  informed consent to participate in the study.

               -  The subject must provide assent when older than 7 years old.

               -  The subjects should have used a pMDI VHC previously and be able to use a VHC with
                  mouthpiece.

               -  The subjects should have been prescribed fluticasone or another inhaled
                  corticosteroid delivered via a pMDI VHC combination.

               -  Clinically stable asthma.

               -  Cooperative, i.e., subject should be able to follow and understand instructions.

               -  The subject must satisfy the study investigator about his/her fitness to
                  participate in the study.

        Exclusion Criteria:

          -  Clinically significant respiratory disease in the previous 4 weeks.

          -  Participation in any other clinical trial in the previous 4 weeks.

          -  Lack of cooperation, subject cannot follow and understand instructions.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>5 Years</minimum_age>
    <maximum_age>8 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ariel Berlinski, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Arkansas</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Arkansas Children's Hospital</name>
      <address>
        <city>Little Rock</city>
        <state>Arkansas</state>
        <zip>72202</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2019</verification_date>
  <study_first_submitted>October 18, 2012</study_first_submitted>
  <study_first_submitted_qc>October 22, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 25, 2012</study_first_posted>
  <results_first_submitted>January 9, 2019</results_first_submitted>
  <results_first_submitted_qc>April 23, 2019</results_first_submitted_qc>
  <results_first_posted type="Actual">April 24, 2019</results_first_posted>
  <last_update_submitted>April 23, 2019</last_update_submitted>
  <last_update_submitted_qc>April 23, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">April 24, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>pediatric</keyword>
  <keyword>asthma</keyword>
  <keyword>metered dose inhaler</keyword>
  <keyword>valved holding chamber</keyword>
  <keyword>pMDI</keyword>
  <keyword>VHC</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Asthma</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Pressurized Metered-Dose Inhaler</title>
          <description>All participants that were consented to use the Pressurized Metered-Dose Inhaler in this study were considered.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="34"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="32"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Equipment malfunction</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>All Study Participants</title>
          <description>All participants that were consented to the study were considered.</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="32"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="6.4" spread="0.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="12"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="20"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>American Indian or Alaska Native</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Asian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Native Hawaiian or Other Pacific Islander</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Black or African American</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>White</title>
                  <measurement_list>
                    <measurement group_id="B1" value="17"/>
                  </measurement_list>
                </category>
                <category>
                  <title>More than one race</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="15"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Height</title>
          <units>centimeters</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="119.3" spread="7.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Weight</title>
          <units>kilograms</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="26.4" spread="8.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Time Using Valved Holding Chamber</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="3" spread="2.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Previous Mouthpiece Experience</title>
          <units>percentage of participants</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="13" spread="41"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Delivered Dose of Fluticasone (on the Filter)</title>
        <description>This is a measure of the the amount of fluticasone deposited onto a filter (delivered dose) during coordinated and uncoordinated actuation/inhalation maneuver. The coordinated maneuver occurs when the firing of the fluticasone is coordinated with the inhalation of the patient . An uncoordinated maneuver occurs when the firing of the fluticasone is coordinated with the exhalation of the patient.</description>
        <time_frame>Day 1</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Age 5-6.5</title>
            <description>Group 1 will consist of 16 children aged 5-6.5 years
Pressurized Metered-Dose Inhaler: Pressurized Metered-Dose Inhaler</description>
          </group>
          <group group_id="O2">
            <title>Aged 6.6- 8 Years</title>
            <description>Group 2 will consist of 16 children aged 6.6- 8 years
Pressurized Metered-Dose Inhaler: Pressurized Metered-Dose Inhaler</description>
          </group>
        </group_list>
        <measure>
          <title>Delivered Dose of Fluticasone (on the Filter)</title>
          <description>This is a measure of the the amount of fluticasone deposited onto a filter (delivered dose) during coordinated and uncoordinated actuation/inhalation maneuver. The coordinated maneuver occurs when the firing of the fluticasone is coordinated with the inhalation of the patient . An uncoordinated maneuver occurs when the firing of the fluticasone is coordinated with the exhalation of the patient.</description>
          <units>Percent filter dose of fluticasone</units>
          <param>Mean</param>
          <dispersion>99% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="16"/>
                <count group_id="O2" value="16"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Coordinated</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="48" lower_limit="44" upper_limit="52"/>
                    <measurement group_id="O2" value="45" lower_limit="39" upper_limit="51"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Uncoordinated</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="41" lower_limit="36" upper_limit="47"/>
                    <measurement group_id="O2" value="40" lower_limit="35" upper_limit="45"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Other</non_inferiority_type>
            <non_inferiority_desc>We used a paired T-test for statistical analysis to compare the filter dose. Using the 1% significance level and assuming a between-subject standard deviation of 60 lg (27%) for the difference between coordinated and doses, 32 subjects are sufficient to detect a 45 lg (20%) difference with 95% confidence.uncoordinated filter</non_inferiority_desc>
            <p_value>&lt;0.001</p_value>
            <method>paired t-test</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Delivered Dose of Fluticasone (on the Filter) Comparing Coordinated and Uncoordinated Maneuvers</title>
        <description>This is a measure of the the amount of fluticasone deposited onto a filter (delivered dose) during coordinated and uncoordinated actuation/inhalation maneuver. The coordinated maneuver occurs when the firing of the fluticasone is coordinated with the inhalation of the patient . An uncoordinated maneuver occurs when the firing of the fluticasone is coordinated with the exhalation of the patient.</description>
        <time_frame>Day 1</time_frame>
        <population>1 participant was excluded from the filter data because they were an outlier</population>
        <group_list>
          <group group_id="O1">
            <title>All Participants</title>
            <description>Data among all participants were compared for the coordinated and uncoordinated effort</description>
          </group>
        </group_list>
        <measure>
          <title>Delivered Dose of Fluticasone (on the Filter) Comparing Coordinated and Uncoordinated Maneuvers</title>
          <description>This is a measure of the the amount of fluticasone deposited onto a filter (delivered dose) during coordinated and uncoordinated actuation/inhalation maneuver. The coordinated maneuver occurs when the firing of the fluticasone is coordinated with the inhalation of the patient . An uncoordinated maneuver occurs when the firing of the fluticasone is coordinated with the exhalation of the patient.</description>
          <population>1 participant was excluded from the filter data because they were an outlier</population>
          <units>Percent filter dose of fluticasone</units>
          <param>Mean</param>
          <dispersion>99% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="31"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Coordinated</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="46" lower_limit="43" upper_limit="50"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Uncoordinated</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="41" lower_limit="37" upper_limit="44"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Inspiratory Peak Flow</title>
        <description>Inspiratory peak flow is a person's maximum speed of inspiration, as measured with a peak flow meter, a small, hand-held device used to monitor a person's ability to breathe in air.
This study compared the inspiratory peak flows of all participants between the coordinated and uncoordinated maneuvers.</description>
        <time_frame>Day 1</time_frame>
        <population>participant was excluded from both the coordinated because of their breathing profile
participants were excluded from the uncoordinated effort because of their breathing profile</population>
        <group_list>
          <group group_id="O1">
            <title>Coordinated Effort</title>
            <description>Data among all participants were compared for the coordinated maneuver.</description>
          </group>
          <group group_id="O2">
            <title>Uncoordinated Effort</title>
            <description>Data among all participants were compared for the uncoordinated maneuver.</description>
          </group>
        </group_list>
        <measure>
          <title>Inspiratory Peak Flow</title>
          <description>Inspiratory peak flow is a person's maximum speed of inspiration, as measured with a peak flow meter, a small, hand-held device used to monitor a person's ability to breathe in air.
This study compared the inspiratory peak flows of all participants between the coordinated and uncoordinated maneuvers.</description>
          <population>participant was excluded from both the coordinated because of their breathing profile
participants were excluded from the uncoordinated effort because of their breathing profile</population>
          <units>L/min</units>
          <param>Mean</param>
          <dispersion>99% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="31"/>
                <count group_id="O2" value="30"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>1st Breath</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="25.2" lower_limit="20.5" upper_limit="30"/>
                    <measurement group_id="O2" value="22.8" lower_limit="17.6" upper_limit="28.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>2nd Breath</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="23.3" lower_limit="18.5" upper_limit="28.1"/>
                    <measurement group_id="O2" value="22" lower_limit="17.3" upper_limit="26.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3rd Breath</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="23.2" lower_limit="18.3" upper_limit="28"/>
                    <measurement group_id="O2" value="22.5" lower_limit="17.1" upper_limit="27.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>All Breaths</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="23.9" lower_limit="21.3" upper_limit="26.5"/>
                    <measurement group_id="O2" value="22.4" lower_limit="19.6" upper_limit="25.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Inspiratory Tidal Volume</title>
        <description>Inspiratory tidal volume is a person's lung volume representing the normal volume of air displaced between normal inhalation and exhalation when extra effort is not applied. In a healthy, young human adult, tidal volume is approximately 500 mL per inspiration or 7 mL/kg of body mass.
This study compared the inspiratory tidal volume of all participants between the coordinated and uncoordinated maneuvers.</description>
        <time_frame>Day 1</time_frame>
        <population>participant was excluded from both the coordinated because of their breathing profile
participants were excluded from the uncoordinated effort because of their breathing profile</population>
        <group_list>
          <group group_id="O1">
            <title>Coordinated Effort</title>
            <description>Data among all participants were compared for the coordinated maneuver.</description>
          </group>
          <group group_id="O2">
            <title>Uncoordinated Effort</title>
            <description>Data among all participants were compared for the uncoordinated maneuver.</description>
          </group>
        </group_list>
        <measure>
          <title>Inspiratory Tidal Volume</title>
          <description>Inspiratory tidal volume is a person's lung volume representing the normal volume of air displaced between normal inhalation and exhalation when extra effort is not applied. In a healthy, young human adult, tidal volume is approximately 500 mL per inspiration or 7 mL/kg of body mass.
This study compared the inspiratory tidal volume of all participants between the coordinated and uncoordinated maneuvers.</description>
          <population>participant was excluded from both the coordinated because of their breathing profile
participants were excluded from the uncoordinated effort because of their breathing profile</population>
          <units>mL</units>
          <param>Mean</param>
          <dispersion>99% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="31"/>
                <count group_id="O2" value="30"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>1st Breath</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="286" lower_limit="209" upper_limit="363"/>
                    <measurement group_id="O2" value="269" lower_limit="212" upper_limit="362"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>2nd Breath</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="281" lower_limit="215" upper_limit="363"/>
                    <measurement group_id="O2" value="259" lower_limit="186" upper_limit="333"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3rd Breath</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="302" lower_limit="227" upper_limit="378"/>
                    <measurement group_id="O2" value="266" lower_limit="201" upper_limit="331"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>All</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="291" lower_limit="250" upper_limit="332"/>
                    <measurement group_id="O2" value="271" lower_limit="228" upper_limit="314"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Measurement Residual Amount of Drug (Fluticasone) Deposited Within the OptiChamber Diamond VHC</title>
        <description>Collect the residual amount of drug (fluticasone) deposited within the OptiChamber Diamond VHC by washing the internal surfaces of the VHC and the Pressurized Metered Dose Inhaler (pMDI) boot</description>
        <time_frame>Day 1</time_frame>
        <population>This is a measure of an inhaler study, not a nebulizer study. Therefore this data was not collected or analyzed as it would not be applicable to this type of study.</population>
        <group_list>
          <group group_id="O1">
            <title>Coordinated Effort</title>
            <description>Data among all participants were compared for the coordinated maneuver.</description>
          </group>
          <group group_id="O2">
            <title>Uncoordinated Effort</title>
            <description>Data among all participants were compared for the uncoordinated maneuver.</description>
          </group>
        </group_list>
        <measure>
          <title>Measurement Residual Amount of Drug (Fluticasone) Deposited Within the OptiChamber Diamond VHC</title>
          <description>Collect the residual amount of drug (fluticasone) deposited within the OptiChamber Diamond VHC by washing the internal surfaces of the VHC and the Pressurized Metered Dose Inhaler (pMDI) boot</description>
          <population>This is a measure of an inhaler study, not a nebulizer study. Therefore this data was not collected or analyzed as it would not be applicable to this type of study.</population>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
                <count group_id="O2" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>1 day</time_frame>
      <group_list>
        <group group_id="E1">
          <title>All Study Participants</title>
          <description>All participants that were consented to the study were considered.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="34"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="34"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Ariel Perlinkski MT</name_or_title>
      <organization>Department of Pediatrics UAMS/COM</organization>
      <email>berlinskiariel@uams.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

